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Abstract
Background: The increase in asthma prevalence until 1990 has been well described. Thereafter, time trends are poorly
known, due to the low number of high quality studies. The preferred method for studying time trends in prevalence is
repeated surveys of similar populations. This study aimed to compare the prevalence of asthma symptoms and their major
determinants, rhinitis and smoking, in Swedish young adults in 1990 and 2008.
Methods: In 1990 the European Community Respiratory Health Survey (ECRHS) studied respiratory symptoms, asthma,
rhinitis and smoking in a population-based sample (86% participation) in Sweden. In 2008 the same symptom questions
were included in the Global Allergy and Asthma European Network (GA
2LEN) survey (60% participation). Smoking questions
were however differently worded. The regions (Gothenburg, Uppsala, Umea ˚) and age interval (20–44 years) surveyed both
in 1990 (n=8,982) and 2008 (n=9,156) were analysed.
Results: The prevalence of any wheeze last 12 months decreased from 20% to 16% (p,0.001), and the prevalence of
‘‘asthma-related symptoms’’ was unchanged at 7%. However, either having asthma attacks or using asthma medications
increased from 6% to 8% (p,0.001), and their major risk factor, rhinitis, increased from 22% to 31%. Past and present
smoking decreased.
Conclusion: From 1990 to 2008 the prevalence of obstructive airway symptoms common in asthma did not increase in
Swedish young adults. This supports the few available international findings suggesting the previous upward trend in
asthma has recently reached a plateau. The fact that wheeze did not increase despite the significant increment in rhinitis,
may at least in part be due to the decrease in smoking.
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Introduction
Asthma is today a global public health issue, following a large
increase in prevalence during the second half of the 20
th
century.[1] The true magnitude of the increase however remains
uncertain since many studies of time trends were either registry
based, did not use general population samples, or compared
prevalence numbers measured using different methodolo-
gies.[2,3]
Accurate data on recent trends in disease are essential to both
public health work and to the allocation of healthcare resources.
Applying the same methodology to similar, representative samples
from the population on two occasions is a reliable way to study
time trends.[4] This method has become predominant in studies of
children, several of which have demonstrated an unchanged
prevalence of asthma in many European countries after year
2000.[5,6] Somewhat surprisingly this repeated survey method has
not been applied to adult populations to the same extent.
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prevalence increase until the 1990s.[7–9] A recent prevalence
study suggested no further increase in asthma in West Sweden
after 1990, when compared with older studies.[10] The only two
recent repeated survey studies have reported a stable prevalence of
adult asthma during the 1990s in Italy and the United
Kingdom.[11,12] Due to this scarcity of repeated surveys reaching
into the 21
st century, further studies are needed.
The prevalence of respiratory symptoms, asthma, rhinitis and
smoking was studied in 1990 in a large, population-based sample
aged 20–44 years in three regions of Sweden as part of the
European Community Respiratory Health Survey (ECRHS).[13]
In 2008 the same questions were included in the Global Allergy
and Asthma European Network survey (GA
2LEN), which was
mailed to 45.000 adults in Sweden. Using these two databases, the
aim of the present study was to compare the prevalence of
respiratory symptoms, asthma, rhinitis and smoking among
Swedish young adults in 2008 with that in 1990.
Materials and Methods
Study areas
Three regions were surveyed: Gothenburg, Uppsala and Umea ˚.
Gothenburg is located at the west coast and is Sweden’s second
largest city. It is the most densely populated study area with the
highest pollution rates, and a mild and humid climate. Uppsala is a
medium-sized university city with low industrial pollution and an
inland climate. Umea ˚, the region capital of Northern Sweden,
comprises both urban and sparsely populated rural areas.
Industrial pollution is low and the climate is sub-arctic.
The 1990 and 2008 surveys
The multinational ECRHS study of asthma symptoms, atopy,
bronchial hyper-responsiveness and risk factors for asthma, was
carried out in 1990.[14] The Swedish participation included a
random sample of 10800 adults aged 20–44 years in Gothenburg,
Uppsala and Umea ˚, identified using the Department of Statistics
of the respective county council offices.[13] In Gothenburg the
Hisingen area was surveyed. The ECRHS questionnaire included
seven questions related to asthma (below) and five questions
related to chronic bronchitis, and has been published in full.[13] It
was translated and back-translated to minimise linguistic bias.
Along with the questionnaire the study subjects received an
invitation letter and a prepaid response envelope. Up to three
reminders were subsequently mailed to non-responders. The final
participation rate was 86%. The Ethics Committees of Gothen-
burg University, Uppsala University and Umea ˚ University, and
the Swedish Data Protection Board approved of the study.
The GA
2LEN network of excellence was launched in 2004 and
includes leading European research centres in the field of allergic
diseases and asthma in 22 countries.[15] The GA
2LEN survey,
carried outin2008,aimedtoassesstheprevalenceofallergicdisease
(asthma, rhinitis, eczema) across Europe. Sweden participated with
four centres: Gothenburg, Stockholm, Uppsala and Umea ˚. A
random sample of 15,000 subjects from Gothenburg and 10,000
subjects from each of the other three cities aged 16–75 years were
selected using civil registries. The questionnaire, in addition to the
seven ECRHS questions on asthma and rhinitis also included
questions related to chronic bronchitis, chronic obstructive
pulmonary disease (COPD), obstructive sleep apnea syndrome
(OSAS), environmental and workplace exposures, physical activity,
and cardiovascular comorbidities. Up to three reminders were
mailed. Sixty percent participated. The Regional Ethical Commit-
tee at Uppsala University approved of the Swedish participation in
the GA
2LEN survey, and of the present ECRHS-GA
2LEN
comparison study. In both surveys the information letter stated
that the data would be stored and used for research purposes.
Participants that answered the questionnaire were thus seen as
having consented to participate in the study. This approach was
approved of by the Ethics Committees both in 1990 and 2008.
Questionnaires and definitions
The ECRHS questions are today widely used and have been
validated against bronchial hyper responsiveness, spirometry and
clinical evaluation by a panel of clinicians.[16,17] The GA
2LEN
questionnaire included seven ECRHS core questions related to
asthma and rhinitis, which have been published in full.[13] Only
definitions of special relevance for the present paper are listed
below.
Any wheeze: ‘‘Have you had wheezing or whistling in your
chest at any time in the last 12 months?’’
Wheeze with breathlessness: ‘‘Have you been at all breathless
when the wheezing noise was present?’’
Wheeze without a cold: ‘‘Have you had this wheezing or
whistling when you did not have a cold?’’
Asthma attacks: ‘‘Have you had an attack of asthma in the last
12 months?’’
Asthma medications: ‘‘Are you currently taking any medicine
(including inhalers, aerosols or tablets) for asthma?’’
Rhinitis: ‘‘Do you have any nasal allergies including hay fever?’’
‘‘Asthma-related symptoms’’: Any wheeze and wheeze with
breathlessness and wheeze without a cold.
‘‘Current asthma’’: ‘‘Do you have asthma?’’ and either or both
of asthma attacks and use of asthma medications.
Ever smoking, 1990: ‘‘Are you an ex-smoker? (quit smoking for
more than one year).’’
Current smoking, 1990: ‘‘Do you smoke? (answer yes even if
you only smoke a few cigarettes or pipes per week or if you quit
smoking for less than one year).’’
Ever smoking .12 months, 2008: ‘‘Have you ever smoked one
or more cigarettes per day for more than one year?’’
Current smoking, 2008: ‘‘…If so, have you at all smoked during
the last month?’’
Statistical analyses
The present study of time trends was limited to the centres
(Gothenburg, Uppsala, Umea ˚) and age interval (20–44 years)
surveyed both in 1990 and 2008. Questionnaires where informa-
tion on any question was missing were eliminated, after which
8982 (4643 female) subjects in 1990 and 9156 (5202 female)
subjects in 2008 remained for analysis.
Forprevalencecomparisonsthe two-sided chi
2 testwasused,with
ap ,0.05 significance level. Prevalence analyses were stratified for
study centre and sex, respectively. For risk analyses multiple logistic
regression was used to calculate Odds Ratios (OR) and 95%
confidence intervals (CI). Interactions were tested by inclusion of
interaction terms (e.g. study year*sex) in the model. All analyses
were performed using SPSS Statistics ver. 11.5 (SPSS Inc, Chicago,
USA). Adjusted population attributable fractions (aPAF) were
calculated from the regression coefficients obtained by multiple
logistic regression, following the method described by Eide et al.
[18] and using STATA 9.1 (STATA Corp, Texas, USA).
Results
Trends in prevalence 1990 to 2008
The prevalence of any wheeze decreased in all centres from
20.3% (95% CI 19.4–21.1%) to 16.1% (15.4–16.9%), p,0.001
Time Trends in Asthma Symptoms in Adults
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wheeze with breathlessness and wheeze without a cold decreased
statistically significantly. The prevalence of ‘‘asthma-related symp-
toms’’ remained at 7% and did not change statistically significantly,
p=0.40. Nocturnal symptoms declined significantly in Gothenburg
and were unchanged in Uppsala and Umea ˚. However, the
prevalence of ‘‘current asthma’’ increased from 6.0% (5.5–6.5%)
to 8.0% (7.4–8.5%), p,0.001, since both asthma attacks and
asthmamedication use increasedstatisticallysignificantlyinall three
centres. A multivariate modeladjusting forage, sexandstudycentre
confirmed these general trends in prevalence (Figure 1). In general,
the prevalence trends were similar in men and women (Table 2).
In 1990, ever smoking and current smoking was reported by
50.1% (49.0–51.1%) and 35.3% (34.3–36.3%) respectively, while
in 2008 ever smoking for more than 12 months and any smoking
last month were reported by 26.0% (25.1–26.9%) and 11.7%
(11.0–12.4%) respectively (Table 1). Smoking prevalence was the
highest in Gothenburg. Among never-smokers the prevalence of
any wheeze and ‘‘asthma-related symptoms’’ did not change
significantly from 1990 to 2008 (Table 3). The prevalence of
‘‘current asthma’’ among never-smokers increased from 6.3%
(5.6–7.0%) to 7.8% (7.2–8.4%), p,0.01, and this increase was
most pronounced in females and in Uppsala.
Asthma and wheeze with rhinitis
The prevalence of rhinitis rose significantly in all centres, from
21.6% (20.7–22.4%)to 30.9% (30.0–31.9%),p,0.001 (Table 1).The
prevalence of any wheeze, ‘‘asthma-related symptoms’’ and ‘‘current
asthma’’ with concurrent rhinitis increased, each p,0.01 (Figure 2).
Meanwhile, the prevalence of any wheeze and ‘‘asthma-related
symptoms’’ without concurrent rhinitis decreased, each p,0.01.
Four mutually exclusive risk groups were studied: non-smokers
without rhinitis, non-smokers with rhinitis, smokers without
rhinitis and smokers with rhinitis (Figure 3). From 1990 to 2008
there were only small changes in the prevalence of any wheeze,
any nocturnal symptom, ‘‘asthma-related symptoms’’ and ‘‘current
asthma’’ within each group. The prevalence of nocturnal
symptoms was around 25% in non-smokers without rhinitis, and
above 50% in smokers with rhinitis. Any wheeze was reported by
30% of subjects with rhinitis, and by 40% of smokers with rhinitis.
Risk factor analysis
Multivariate analysis demonstrated that the major risk factors for
any wheeze were rhinitis, OR 3.65 (95% CI 3.36–3.96) and current
smoking, OR 2.71 (2.47–2.98) (Table 4). This was similar to
‘‘asthma-related symptoms’’, where rhinitis had OR 4.71 (4.18–
5.30) and current smoking OR 2.08 (1.81–2.39). ‘‘Current asthma’’
was strongly associated with rhinitis, OR 9.02 (7.92–10.3) but
showed no association with smoking, and was significantly less
common in subjects aged over 30 years. Living in Umea ˚ was
associated with the highest risk for all three outcomes (ORs 1.2).
The majority of associations were of similar strength 1990 and
2008 (Table 5). However, there was a downward trend over time
in the association of living in Gothenburg with wheeze and
‘‘asthma-related symptoms’’ (p=0.02, p=0.09 for the interaction
term study year*Gothenburg). Risk associations by smoking status
are presented in tables 6 and 7. Notably, in 2008 female sex was a
significant risk factor among ever smokers only (Table 7).
Adjusted population attributable fractions (aPAF) were calcu-
lated from multivariate ORs and risk factor prevalence (Figure 4).
For any wheeze, in 1990 rhinitis and current smoking each had
aPAF around 25% whereas in 2008, aPAF was 40% for rhinitis
and 10% for smoking. This pattern was seen also for ‘‘asthma-
related symptoms’’, only with greater aPAF of rhinitis in both
surveys. For ‘‘current asthma’’, the aPAF of rhinitis was around
60% in both surveys while that of smoking was negligible.
Table 1. Prevalence (%) of respiratory symptoms in the last twelve months and of smoking, in 1990 and 2008, by study centre.
All Go ¨teborg Uppsala Umea ˚
1990 2008
Mean
diff.* P 1990 2008 P 1990 2008 P 1990 2008 P
Wheeze Any 20.3 16.1 24.2 ,0.001 22.5 15.7 ,0.001 18.6 15.7 0.005 19.9 17.1 0.005
with breathlessness 11.2 10.2 21.0 0.035 11.9 9.4 0.001 10.3 10.4 0.947 11.3 11.1 0.812
without a cold 12.1 10.2 21.9 ,0.001 13.1 9.4 ,0.001 11.2 9.8 0.102 12.2 11.8 0.620
‘‘Asthma-related symptoms’’ 7.2 6.9 20.3 0.396 7.3 6.1 0.051 6.6 7.1 0.522 7.7 7.9 0.802
Woken by
chest tightness 11.2 10.9 20.3 0.474 14.2 10.7 ,0.001 9.4 10.6 0.119 10.4 11.3 0.274
breathlessness 5.3 4.9 20.4 0.239 6.9 5.0 0.002 4.8 4.5 0.653 4.4 5.1 0.262
cough 26.6 24.7 21.9 0.003 27.7 20.7 ,0.001 25.3 27.1 0.116 26.9 27.8 0.449
Asthma attack 3.2 4.4 +1.3 ,0.001 3.0 3.7 0.130 3.1 4.5 0.007 3.3 5.4 ,0.001
Asthma
medications
5.2 6.9 +1.7 ,0.001 4.6 6.1 0.009 4.6 7.0 ,0.001 6.2 7.9 0.011
‘‘Current asthma’’ 6.0 8.0 +1.9 ,0.001 5.5 6.9 0.002 5.7 8.1 ,0.001 6.8 9.3 ,0.001
Rhinitis 21.6 30.9 +9.4 ,0.001 21.7 31.5 ,0.001 22.0 30.9 ,0.001 21.1 30.2 ,0.001
Smoking
ever 50.1 - 55.2 - 48.3 - 47.4 -
current 35.3 - 42.2 - 33.6 - 31.1 -
.12 months ever - 26.0 - 30.7 - 25.2 - 20.1
last month - 11.7 - 14.5 - 11.1 - 8.3
*Mean difference 2008 vs. 1990, absolute percentage.
doi:10.1371/journal.pone.0016082.t001
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Women Men
1990
n=4643
2008
n=5202 Mean diff.* P
1990
n=4339
2008
n=3954 Mean diff.* P
Wheeze Any 21.0 16.6 24.4 ,0.001 19.5 15.5 24.0 ,0.001
with breathlessness 11.9 10.8 21.1 0.084 10.4 9.4 21.0 0.144
without a cold 11.8 10.4 21.4 0.032 12.5 10.0 22.5 ,0.001
‘‘Asthma-related symptoms’’ 7.2 7.1 20.1 0.906 7.3 6.6 20.7 0.239
Woken by
chest tightness 11.0 12.0 +1.0 0.133 11.4 9.4 22.0 0.003
Breathlessness 5.6 5.2 20.4 0.348 5.0 4.6 20.4 0.394
Cough 32.4 30.4 22.0 0.029 20.4 17.1 23.2 ,0.001
Asthma attack 3.4 5.2 +1.8 ,0.001 3.0 3.5 +0.5 0.204
Asthma medications 5.4 7.2 +1.8 ,0.001 4.9 6.4 +1.5 0.003
‘‘Current asthma’’ 6.3 8.5 +2.2 ,0.001 5.7 7.2 +1.5 0.005
Rhinitis 21.2 30.5 +9.3 ,0.001 21.9 31.5 +9.5 ,0.001
Smoking
Ever 51.2 - 48.8 -
current 36.7 - 33.8 -
.12 months ever - 27.8 - 23.6
Last month - 12.2 - 10.6
doi:10.1371/journal.pone.0016082.t002
Figure 1. Adjusted odds ratios of study year 2008 vs. 1990. Multiple logistic regression analysis was performed with adjustment for age (20–
27, 28–35, 36–44 years), sex and study centre. 95% confidence intervals are included.
doi:10.1371/journal.pone.0016082.g001
Time Trends in Asthma Symptoms in Adults
PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e16082Discussion
This large, population-based repeated survey study found no
further increase after 1990 in wheezing indices and ‘‘asthma-
related symptoms’’ among Swedish young adults. In fact, the
prevalence of any wheeze decreased from 1990 to 2008, whereas
the prevalence of asthma attacks and the use of asthma medication
increased slightly. The prevalence of rhinitis, on the other hand,
increased considerably. Smoking, although surveyed differently in
1990 and 2008, seemed to decrease.
Strengths and limitations
The present study benefitted from applying the same standard-
ised ECRHS core questions to two comparable large general
population samples surveyed 18 years apart. Asking about
symptoms is less likely biased by health care practice and diagnostic
activity than is e.g. asthma diagnoses. Two findings indicated that
the core questions targeted similar respiratory symptoms both years.
First, the associations of respiratory symptoms with smoking and
rhinitis were very similar in 1990 and 2008. Second, the prevalence
of other respiratory symptoms among subjects with any wheeze,
‘‘asthma-related symptoms’’ and ‘‘current asthma’’ were also
comparable in both surveys (data not shown).
The age spans and regions surveyed were similar in 1990 and
2008. The choice of age span minimises the risk of misclassifica-
tion with COPD, however, the findings cannot be readily
generalised to older adults. The three study areas were chosen
so as to represent the geographical (north vs. south, inland vs.
coastal, west vs. east coast) and demographical (large city, medium-
sized city and a smaller community) features of Sweden.[13] In
1990, the Gothenburg survey was carried out in the area of
Hisingen, which had lower mean incomes and a higher proportion
of immigrants than the rest of the city.[13] In 2008 a general
Gothenburg population sample was invited instead. However, the
major trends in any wheeze, ‘‘asthma-related symptoms’’ and
rhinitis were seen also in Umea ˚ and Uppsala, and in another study
of Gothenburg.[10] Moreover, adjustment for differences in the
study populations did not change these observations (Figure 1).
A decreased participation, as seen in 2008 compared to 1990,
may have lead to overestimation of symptom prevalence [19] in
the latter survey. The resulting false-positive prevalence trend
would however not contradict our main finding that prevalence
did not increase. Also, a recent Swedish study, which included a
subsample from the present study, found no evidence of such
participation bias of respiratory symptoms.[20]
Trends in symptoms of asthma
Asthma is a heterogeneous disease. We thus sought to mirror the
panorama of respiratory morbidity from any wheeze to more
specific‘‘asthma-related symptoms’’.[11,13]Theoutcome‘‘asthma-
related symptoms’’ reflects both non-allergic and allergic asthma
and bronchial hyper-reactivity [13] and was closely related to
smoking and rhinitis. Any wheeze, in contrast, seemingly had other
significant determinants, as suggested by the low aPAFs of smoking
andrhinitis.Thenegativetime trendinanywheeze,OR0.83(0.76–
0.90), when adjusted for rhinitis and ever smoking probably
Table 3. Prevalence (%) of any wheeze, ‘‘asthma-related symptoms’’ and ‘‘current asthma’’ in never-smokers, in 1990 and 2008
respectively.
Any wheeze ‘‘Asthma-related symptoms’’ ‘‘Current asthma’’
1990 2008 P 1990 2008 P 1990 2008 P
All 14.4 14.2 0.704 5.7 6.2 0.284 6.3 7.8 0.003
Sex Female 14.4 14.5 0.922 5.9 6.4 0.511 6.0 7.9 0.007
Male 14.5 14.0 0.595 5.5 6.0 0.361 6.6 7.7 0.106
Age 20–24 yrs 15.0 14.3 0.546 6.9 6.8 0.924 7.9 8.4 0.616
25–29 yrs 13.7 14.2 0.694 5.1 6.1 0.292 6.1 7.7 0.119
30–34 yrs 13.2 13.0 0.876 5.6 6.3 0.504 4.7 7.1 0.023
35–39 yrs 15.0 15.2 0.907 5.2 6.3 0.350 5.4 8.1 0.027
40–44 yrs 15.4 14.8 0.753 4.5 5.0 0.678 5.9 7.4 0.258
Centre Gothenburg 15.0 12.8 0.070 4.9 4.7 0.807 5.8 6.6 0.317
Umea ˚ 15.5 15.7 0.862 6.4 7.4 0.201 7.6 9.2 0.075
Uppsala 12.9 14.5 0.171 5.6 6.8 0.138 5.3 7.9 0.002
doi:10.1371/journal.pone.0016082.t003
Figure 2. Prevalence stratified by rhinitis. Prevalence (%) of any
wheeze, ‘‘asthma-related symptoms’’ and ‘‘current asthma’’ with and
without rhinitis, respectively, in 1990 and 2008.
doi:10.1371/journal.pone.0016082.g002
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workplace exposures. The decrease in any wheeze, although seen in
all study centres, was most pronounced in Gothenburg. Analogous-
ly, the other two wheezing indices were unchanged in Umea ˚a n d
Uppsala, and decreased in Gothenburg. The differences between
1990 and 2008 in the Gothenburg population composition, as
discussed above, may have led to an overestimation of the negative
trend. On the contrary, lower participation in 2008 may have
biased the prevalence slightly upwards.[19] Taking these uncer-
tainties into consideration, our conservative conclusion is that there
was no evidence of a continuation of the previous upward trend in
obstructive symptoms.
In contrast to any wheeze and the other wheezing indices, the
prevalence of ‘‘current asthma’’ increased slightly. There are
several possible explanations for this. First, one would expect a real
increase in the prevalence of ‘‘current asthma’’ driven by the large
increase in rhinitis, to which current asthma was strongly
associated. Second, by its definition ‘‘current asthma’’ is affected
by secular trends in prescription patterns and by the labelling of
respiratory symptoms as ‘‘asthma’’. In Sweden awareness of
Figure 3. Prevalence in four mutually exclusive risk groups. Prevalence (%) of any wheeze, ‘‘asthma-related symptoms’’, ‘‘current asthma’’ and
of any nocturnal symptom, in four subgroups based on current smoking (yes/no) and rhinitis (yes/no). White bars: Study year 1990. Grey bars: Study
year 2008. * denotes p,0.05.
doi:10.1371/journal.pone.0016082.g003
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[6,10] and this may have contributed to the observed increase.
This inherent limitation and the fact that other obstructive
symptoms did not increase or even decreased, argue that a true
increase in asthma prevalence cannot be directly inferred from the
increase in ‘‘current asthma’’. If anything, it may reflect a slight
change in the spectrum of respiratory symptoms between 1990
and 2008.
In the Scandinavian countries, including Sweden, a rise in
asthma was seen between the 1970s and 1990s.[7–9,21] Recently,
a subset comparison indicated no increase in asthma symptoms in
West Sweden,[10] and the present study confirms these findings
outside that region as well. In Swedish schoolchildren, no increase
in asthma symptoms was seen 1996–2006.[6] These indications of
a break of the previous upward trend in Sweden warrants further
up-to-date studies in the other Scandinavian countries.
Table 4. Risk factors, including study year, for ‘‘asthma-related symptoms’’, ‘‘current asthma’’ and any wheeze by multiple logistic
regression analysis.
‘‘Asthma-related symptoms’’ ‘‘Current asthma’’ Any wheeze
OR (95% CI) OR (95% CI) OR (95% CI)
Study year 2008 (vs. 1990) 0.98 (0.86–1.11) 1.12 (0.98–1.27) 0.83 (0.76–0.90)
Female sex 1.03 (0.92–1.16) 1.19 (1.06–1.34) 1.09 (1.00–1.17)
Age (vs. 20–24 yrs)
25–29 yrs 0.92 (0.77–1.10) 0.86 (0.72–1.03) 1.01 (0.90–1.15)
30–34 yrs 0.90 (0.75–1.09) 0.74 (0.61–0.89) 0.93 (0.82–1.06)
35–39 yrs 0.92 (0.76–1.11) 0.79 (0.65–0.95) 1.02 (0.90–1.17)
40–44 yrs 0.95 (0.79–1.15) 0.78 (0.64–0.94) 1.07 (0.94–1.22)
Centre (vs. Uppsala)
Umea ˚ 1.20 (1.04–1.38) 1.24 (1.07–1.44) 1.15 (1.04–1.27)
Gothenburg 0.91 (0.79–1.06) 0.87 (0.75–1.02) 1.06 (0.96–1.17)
Rhinitis 4.71 (4.18–5.30) 9.02 (7.92–10.3) 3.65 (3.36–3.96)
Smoking (vs. never)
Ever 1.10 (0.91–1.31) 1.07 (0.90–1.28) 1.16 (1.02–1.31)
Current 2.08 (1.81–2.39) 1.09 (0.93–1.28) 2.71 (2.47–2.98)
All variables in the table were included in the model. Associations are presented as Odds Ratios (OR) with 95% confidence intervals (95% CI). Statistically significant
associations in bold text.
doi:10.1371/journal.pone.0016082.t004
Table 5. Risk factors for ‘‘asthma-related symptoms’’, ‘‘current asthma’’ and any wheeze by multiple logistic regression analysis, in
1990 and 2008 respectively.
‘‘Asthma-related symptoms’’ ‘‘Current asthma’’ Any wheeze
1990
OR (95% CI)
2008
OR (95% CI)
1990
OR (95% CI)
2008
OR (95% CI)
1990
OR (95% CI)
2008
OR (95% CI)
Female sex 0.98 (0.83–1.15) 1.08 (0.91–1.28) 1.15 (0.96–1.39) 1.22 (1.04–1.44) 1.08 (0.97–1.21) 1.09 (0.96–1.22)
Age (vs. 20–24 yrs)
25–29 yrs 0.91 (0.71–1.16) 0.95 (0.74–1.21) 0.80 (0.61–1.04) 0.91 (0.73–1.15) 1.00 (0.85–1.18) 0.98 (0.82–1.16)
30–34 yrs 0.85 (0.66–1.09) 0.90 (0.70–1.16) 0.65 (0.49–0.87) 0.83 (0.65–1.06) 0.99 (0.84–1.16) 0.90 (0.75–1.08)
35–39 yrs 0.85 (0.66–1.09) 1.05 (0.81–1.35) 0.77 (0.58–1.01) 0.93 (0.73–1.19) 0.98 (0.83–1.16) 1.07 (0.89–1.28)
40–44 yrs 1.11 (0.86–1.43) 0.82 (0.62–1.09) 0.75 (0.56–1.01) 0.77 (0.59–1.01) 1.08 (0.91–1.29) 1.06 (0.87–1.28)
Centre (vs. Uppsala)
Umea ˚ 1.23 (1.01–1.50) 1.17 (0.95–1.44) 1.29 (1.04–1.60) 1.21 (0.99–1.48) 1.14 (1.00–1.30) 1.16 (0.995–1.35)
Gothenburg 1.03 (0.84–1.27) 0.81 (0.66–0.998) 0.96 (0.76–1.22) 0.82 (0.67–0.996) 1.18 (1.03–1.35) 0.95 (0.82–1.09)
Rhinitis 4.44 (3.76–5.24) 5.05 (4.25–6.00) 10.2 (8.45–12.4) 8.06 (6.77–9.60) 3.30 (2.94–3.71) 4.06 (3.61–4.56)
Smoking (vs. never)
Ever 0.98 (0.74–1.29) 1.21 (0.96–1.54) 1.18 (0.90–1.56) 1.00 (0.79–1.26) 1.17 (0.98–1.40) 1.16 (0.98–1.40)
Current 2.14 (1.79–2.55) 1.92 (1.53–2.40) 1.05 (0.85–1.29) 1.21 (0.95–1.54) 2.84 (2.52–3.20) 2.43 (2.08–2.85)
All variables in the table were included in the model. Associations are presented as Odds Ratios (OR) with 95% confidence intervals (95% CI). Statistically significant
associations in bold text.
doi:10.1371/journal.pone.0016082.t005
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thoroughly.[22,23] A review concluded that the prevalence
plateaued during the 1990s after increasing since the 1970s,[12]
a conclusion, however, in part based on registry studies and studies
of selected populations.[22] The present study corroborates these
findings despite the higher asthma prevalence in the UK.
Hypothetically, this could indicate that trends in prevalence
correlate better to events in time than to absolute prevalence,
analogous to recent observations in children.[5,6,12] Hopefully,
further studies will determine whether in fact a plateau in
prevalence has developed simultaneously in children and adults.
Registry-based studies have indicated a level asthma prevalence
during the 1990s also in Mexico, Canada and the US.[24–26] In an
Italian repeated survey study the prevalence of asthma attacks, wheeze
and ‘‘asthma-related symptoms’’ was unchanged during the 1990s,
breaking a previous upward trend.[11,27] Regrettably, the Italian
study did not include trends in risk factors. Unlike the Italian authors
we do not believe that increased medication explains the decrease in
any wheeze, since also the prevalence of either having wheeze or using
medications decreased in our study, 21.2%–17.8%, p,0.001.
Taken together, our results in conjunction with previous
findings provide increasing evidence that asthma in adults has
reached a plateau in prevalence in several Westernised countries
after 1990. This relatively simultaneous development in geograph-
ically very different locations is in itself an important observation,
as it would argue against some aetiological factors, e.g. certain
allergens, as a major explanation. However, until more studies
include trends in determinants of asthma, researchers can only
speculate about the underlying aetiologies.
Trends in rhinitis and smoking
The mean annual increase in rhinitis was 0.52% in our study,
similar to 0.41% in Italy 1991–1998.[11] An increase in rhinitis
was also seen in a Danish study which included serological tests for
Table 6. Risk factors in never-smokers and ever smokers in 1990 by multiple logistic regression analysis.
‘‘Asthma-related symptoms’’ ‘‘Current asthma’’ Any wheeze
Never-smokers Ever smokers Never-smokers Ever smokers Never-smokers Ever smokers
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Female sex 0.94 (0.72–1.21) 1.04 (0.74–1.48) 1.13 (0.88–1.46) 1.16 (0.89–1.51) 1.01 (0.85–1.20) 1.13 (0.99–1.30)
Age (vs. 20–24 yrs)
25–29 yrs 0.74 (0.51–1.06) 1.04 (0.74–1.48) 0.76 (0.54–1.07) 0.89 (0.58–1.38) 0.91 (0.71–1.16) 1.01 (0.81–1.26)
30–34 yrs 0.78 (0.54–1.14) 0.85 (0.60–1.21) 0.55 (0.38–0.82) 0.82 (0.54–1.25) 0.85 (0.66–1.10) 0.95 (0.76–1.18)
35–39 yrs 0.78 (0.52–1.16) 0.85 (0.61–1.19) 0.68 (0.45–1.01) 0.92 (0.61–1.37) 1.03 (0.79–1.34) 0.85 (0.68–1.05)
40–44 yrs 0.71 (0.45–1.12) 1.22 (0.88–1.70) 0.81 (0.53–1.23) 0.79 (0.51–1.22) 1.12 (0.85–1.48) 0.90 (0.73–1.13)
Centre (vs. Uppsala)
Gothenburg 0.92 (0.65–1.29) 1.18 (0.91–1.54) 1.15 (0.82–1.62) 0.81 (0.58–1.12) 1.23 (0.99–1.54) 1.21 (1.03–1.43)
Umea ˚ 1.14 (0.84–1.53) 1.24 (0.95–1.62) 1.46 (1.09–1.97) 1.11 (0.81–1.53) 1.24 (1.01–1.52) 1.04 (0.88–1.24)
Rhinitis 6.00 (4.60–7.79) 3.44 (2.77–4.28) 9.71 (7.42–12.7) 10.9 (8.28–14.4) 4.01 (3.37–4.77) 2.65 (2.27–3.10)
All variables in the table were included in the model. Associations are presented as Odds Ratios (OR) with 95% confidence intervals (95% CI). Statistically significant
associations in bold text.
doi:10.1371/journal.pone.0016082.t006
Table 7. Risk factors in never-smokers and ever smokers in 2008 by multiple logistic regression analysis.
‘‘Asthma-related symptoms’’ ‘‘Current asthma’’ Any wheeze
Never-smokers Ever smokers Never-smokers Ever smokers Never-smokers Ever smokers
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Female sex 0.96 (0.78–1.18) 1.40 (1.03–1.91) 1.00 (0.83–1.21) 2.34 (1.64–3.33) 0.99 (0.86–1.15) 1.30 (1.06–1.61)
Age (vs. 20–24 yrs)
25–29 yrs 0.88 (0.66–1.17) 1.13 (0.70–1.82) 0.87 (0.67–1.12) 1.14 (0.70–1.84) 0.97 (0.79–1.19) 0.92 (0.66–1.28)
30–34 yrs 0.90 (0.67–1.21) 0.87 (0.53–1.43) 0.79 (0.60–1.05) 1.00 (0.61–1.63) 0.86 (0.70–1.07) 0.83 (0.59–1.16)
35–39 yrs 0.86 (0.63–1.18) 1.39 (0.87–2.22) 0.88 (0.66–1.17) 1.13 (0.69–1.84) 1.02 (0.82–1.27) 0.96 (0.69–1.34)
40–44 yrs 0.67 (0.47–0.97) 1.07 (0.66–1.74) 0.80 (0.59–1.10) 0.74 (0.43–1.24) 1.00 (0.79–1.27) 0.99 (0.71–1.38)
Centre (vs. Uppsala)
Gothenburg 0.68 (0.53–0.88) 1.12 (0.79–1.60) 0.83 (0.66–1.05) 0.77 (0.53–1.11) 0.87 (0.73–1.04) 1.15 (0.90–1.46)
Umea ˚ 1.14 (0.89–1.46) 1.19 (0.79–1.79) 1.23 (0.98–1.55) 1.15 (0.76–1.74) 1.13 (0.95–1.35) 1.20 (0.90–1.60)
Rhinitis 5.87 (4.73–7.27) 3.76 (2.80–5.03) 7.70 (6.29–9.42) 9.24 (6.51–13.1) 4.43 (3.84–5.10) 3.23 (2.64–3.95)
All variables in the table were included in the model. Associations are presented as Odds Ratios (OR) with 95% confidence intervals (95% CI). Statistically significant
associations in bold text.
doi:10.1371/journal.pone.0016082.t007
Time Trends in Asthma Symptoms in Adults
PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e16082allergic sensitisation.[28] In contrast, in Melbourne, Australia, the
prevalence of rhinitis was unchanged 1990–1999.[29] However,
this could be reflect a saturation effect, since the prevalence in
Melbourne in 1990 was almost twice that in our study. In 1990 the
sensitisation rate was 76% among adults with rhinitis in the
Swedish ECRHS centres. Provided this proportion did not change
1990–2008 our results may suggest an increase in sensitisation
among Swedish adults. Without objective testing this, however,
remains a speculation.
Although lower participation and the more stringent wording in
2008 of the questions about smoking may have biased the trend in
smoking prevalence downward, our results are very similar to several
recent Swedish population-based studies [6,10] and also to Swedish
official census data.[30] This is firm evidence of a real decrease in
smoking, which may have been related to recent smoking restrictions,
raised tobacco taxes and information campaigns.
For a multifactorial disease with complex cause-consequence
relationships such as asthma, exact attributable fractions cannot be
calculatedfrom singleriskfactorodds ratios. Risk factorassociations
may also be biased: Physicians may be more prone to diagnose
rhinitis in asthmatic subjects, or to label wheeze among smokers as
COPD. We however used aPAF, which takes both risk factor
prevalence and strength of association into account, as a crude
proxy to detect large-scale trends in risk factors in the population.
Using the approximations of risk in our study it seems that, at a
population level, the importance of smoking decreased while that of
rhinitis increased. These changes were mainly due to changed
prevalence of smoking and rhinitis, which is less subject to
association bias, above. We speculate that the decrease in smoking
is one reason why the prevalence of wheeze and ‘‘asthma
symptoms’’ did not increase to the same extent that did rhinitis.
Conclusion
In conclusion, the present study demonstrated that symptoms of
airway obstruction have not increased in prevalence since 1990 in
Swedish young adults. The observed decrease in smoking may be
one explanatory factor. A moderate increase was however seen for
asthma attacks and use of asthma medications. Despite the
possible bias from changed awareness, this finding may indicate a
slight shift in respiratory symptom expression, related to the
significant increase in rhinitis. Although the studies are still few,
there seems to be a general trend toward a plateau in asthma in
Westernised countries. The fact that this seemingly has occurred
simultaneously in children and adults, and in several parts of the
world, may provide an important clue in understanding the
development of the asthma epidemic.
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